Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cash, Cash Equivalents and Short-Term Investments (Tables)

Cash, Cash Equivalents and Short-Term Investments (Tables)

3 Months Ended

Mar. 31, 2015

Cash, Cash Equivalents and Short-Term Investments

Schedule of cash, cash equivalents and short-term investments

Cash, cash equivalents and short-term investments consist of the following (in thousands);

	March 31,		December 31,
	2015		2014
Checking account	$	1,143	$	175
Money market funds	26,978		10,027
U.S. treasury bills	—		2,010
Government-sponsored enterprise securities	42,129		45,786
Corporate bonds and commercial paper	90,905		85,161
	$	161,155	$	143,159
Reported as:
Cash and cash equivalents	$	42,718	$	15,203
Short-term investments	118,437		127,956
	$	161,155	$	143,159

Schedule of cash equivalents and short-term investments including the securities with unrealized gains and losses

Cash equivalents and short-term investments include the following securities with gross unrealized gains and losses (in thousands):

			Gross		Gross
	Amortized		Unrealized		Unrealized
March 31, 2015	Cost		Gains		Losses			Fair Value
Government-sponsored enterprise securities	$	42,127	$	6	$	(4	)	$	42,129
Corporate bonds and commercial paper	90,890		28		(13		)	90,905

Total	$	133,017	$	34	$	(17	)	$	133,034

			Gross		Gross
	Amortized		Unrealized		Unrealized
December 31, 2014	Cost		Gains		Losses			Fair Value
U.S. treasury bills	$	2,010	$	—	$	—		$	2,010
Government-sponsored enterprise securities	45,793		4		(11		)	45,786
Corporate bonds and commercial paper	85,161		21		(21		)	85,161

Total	$	132,964	$	25	$	(32	)	$	132,957

Schedule of contractual maturities of cash equivalents and short-term investments

As of March 31, 2015, the contractual maturities of our cash equivalents and short-term investments were (in thousands):

	Years to Maturity
			After One Year
	Within One		Through
	Year		Two Years
Government-sponsored enterprise securities	$	39,129	$	3,000
Corporate bonds and commercial paper	90,905		—
	$	130,034	$	3,000

Schedule of fair value and gross unrealized losses of the entity's investments in unrealized loss position

The following table shows the fair value and gross unrealized losses of our investments in individual securities that are in an unrealized loss position, aggregated by investment category (in thousands):

			Unrealized
March 31, 2015	Fair Value		Losses
Government-sponsored enterprise securities	$	22,078	$	(4	)
Corporate bonds and commercial paper	29,145		(13		)
Total	$	51,223	$	(17	)